Literature DB >> 19259739

Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization.

Toshiya Kamiyama1, Kazuaki Nakanishi, Hideki Yokoo, Hirofumi Kamachi, Munenori Tahara, Tomomi Suzuki, Tsuyoshi Shimamura, Hiroyuki Furukawa, Michiaki Matsushita, Satoru Todo.   

Abstract

BACKGROUND: Bridge hepatectomy followed by salvage liver transplantation has been proposed for patients with hepatocellular carcinoma (HCC) and preserved liver function.
METHODS: Data were prospectively collected for 501 consecutive patients who underwent curative primary hepatectomy for HCC between 1990 and 2006. Patient survival, disease-free survival (DFS), recurrence patterns, and risk factors were analyzed in patients classified according to the Milan criteria.
RESULTS: Patients were divided into two groups on the basis of whether their disease was within the Milan criteria (group 1, n = 321) or not (group 2, n = 180). Group 1 patient survival and DFS rates were 73.6% and 40.6% at 5 years. Recurrence was observed in 160 group 1 patients (49.8%); in 42 (26.3%) of these 160 patients, the recurrence exceeded the Milan criteria. No recurrence was noted in 145 group 1 patients (45.2%). Group 2 patient survival and DFS rates were 52.2% and 23.2%, respectively, at 5 years. Recurrence was noted in 116 patients (64.4%); recurrence in 58 (50.0%) of these patients was within the Milan criteria. In group 2, no recurrence was noted in 55 patients (30.6%). In group 1, indocyanine green retention rate at 15 minutes of >15%, nonanatomical resection, and multiple tumors were statistically significant risk factors for survival; 10-year patient survival was 78.5% for patients with no risk factors and 64.9% for patients with a single risk factor.
CONCLUSIONS: The Milan criteria should be used to recommend hepatectomy for patients with HCC; however, it is important to consider the high recurrence rate after hepatectomy and the possible requirement of salvage transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19259739     DOI: 10.1245/s10434-009-0407-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  38 in total

1.  Impact of the preoperative des-gamma-carboxy prothrombin level on prognosis after hepatectomy for hepatocellular carcinoma meeting the Milan criteria.

Authors:  Takanori Sakaguchi; Shohachi Suzuki; Yoshifumi Morita; Kousuke Oishi; Atsushi Suzuki; Kazuhiko Fukumoto; Keisuke Inaba; Satoshi Nakamura; Hiroyuki Konno
Journal:  Surg Today       Date:  2010-06-26       Impact factor: 2.549

2.  Microvascular infiltration has limited clinical value for treatment and prognosis in hepatocellular carcinoma.

Authors:  Nazario Portolani; Gian Luca Baiocchi; Sarah Molfino; Anna Benetti; Federico Gheza; Stefano Maria Giulini
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

3.  Effects of nitric oxide on the biological behavior of HepG2 human hepatocellular carcinoma cells.

Authors:  Lei Zhou; Heng Zhang; Jie Wu
Journal:  Exp Ther Med       Date:  2016-03-02       Impact factor: 2.447

4.  Significance of platelet count in the outcomes of hepatectomized patients with hepatocellular carcinoma exceeding the Milan criteria.

Authors:  Hironobu Amano; Hirotaka Tashiro; Akihiko Oshita; Tsuyoshi Kobayashi; Yoshisato Tanimoto; Shintaro Kuroda; Hirofumi Tazawa; Toshiyuki Itamoto; Toshimasa Asahara; Hideki Ohdan
Journal:  J Gastrointest Surg       Date:  2011-04-22       Impact factor: 3.452

5.  Comments on "JAMA PATIENT PAGE. Treatment of Liver Cancer".

Authors:  Chengpei Zhu; Qinjuan Qian; Xiangchao Meng; Haitao Zhao
Journal:  Hepatobiliary Surg Nutr       Date:  2017-02       Impact factor: 7.293

6.  Correlation of LAPTM4B polymorphisms with hepatocellular carcinoma in Chinese patients.

Authors:  Guojun Zhai; Hua Yang; Xiaoxu Ji; Fuxia Xiong; Jing Su; Michael A McNutt; Xuan Li
Journal:  Med Oncol       Date:  2011-12-30       Impact factor: 3.064

7.  Resection of a transplantable single-nodule hepatocellular carcinoma in Child-Pugh class A cirrhosis: factors affecting survival and recurrence.

Authors:  Fabrice Muscari; Bertrand Foppa; Nicolas Carrere; Nassim Kamar; Jean-Marie Peron; Bertrand Suc
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

8.  Predicting recurrence patterns after resection of hepatocellular cancer.

Authors:  Ser Yee Lee; Ioannis T Konstantinidis; Anne A Eaton; Mithat Gönen; T Peter Kingham; Michael I D'Angelica; Peter J Allen; Yuman Fong; Ronald P DeMatteo; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2014-07-16       Impact factor: 3.647

9.  LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.

Authors:  Hua Yang; Fu Xia Xiong; Ming Lin; Yu Yang; Xiu Nie; Rou Li Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-19       Impact factor: 4.553

10.  Reduced expression of ASS is closely related to clinicopathological features and post-resectional survival of hepatocellular carcinoma.

Authors:  Hua Yang; Ming Lin; Fu Xia Xiong; Yu Yang; Xiu Nie; Rou Li Zhou
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.